Speaker: Kate Elder, Vaccines policy advisor
World Health Assembly 67
Agenda item 12.2
Médecins Sans Frontières welcomes and notes the recommendations of the Strategic Advisory Group of Experts on the first Global Vaccine Action Plan annual report. Improving the availability and quality of data on vaccine prices – as recommended in the Secretariat’s report - should be a priority for the GVAP.
Currently, the only data that is publicly available on a systematic basis are the prices paid by the PAHO Revolving Fund and UNICEF for GAVI-supported vaccines. It is otherwise unclear what most countries pay for their vaccines.
When the GVAP was adopted two years ago, a number of Member States raised concerns on the lack of vaccine affordability and the extremely high prices paid by many middle-income countries. Member States urged the GVAP Secretariat to play an active role in improving affordability so that all countries can benefit.
According to the lowest publicly-published prices – which aren’t available to most countries in this room – the cost of fully vaccinating a child has increased by 2,700% over the last decade. A significant portion of the US$51 billion Decade of Vaccines is allocated for the cost of the vaccines alone; it’s therefore critical that their price be monitored, particularly for countries that will lose GAVI support, and the middle-income countries that increasingly cannot afford these high costs. Because of price, we now see the paradox of middle-income countries introducing new vaccines – such as those against pneumonia rotavirus and HPV – at a slower rate than the poorest countries that receive GAVI support.
The SAGE recommendations to the GVAP Secretariat last November – on securing information on prices and improving the indicators for tracking affordability – should be implemented.
MSF urges Members States to support this by:
- Reporting prices paid by the public sector for vaccines to the GVAP Secretariat on an annual basis; and
- Helping the Secretariat to secure information on prices in self-procuring middle-income countries, high-income countries and the private market, in order to get a comprehensive picture of the global vaccine market.
Give All Children A Fair Shot
Join us in demanding a lower price
for pneumonia vaccine, and help save nearly
1 million children every year!